ACHIEVE LIFE SCIENCES, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Achieve Life Sciences, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Achieve Life Sciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 7, 2024 was 34.4M shares, a 62.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 34.4M +13.2M +62.5% Nov 7, 2024 10-Q 2024-11-07
Q2 2024 34.3M +13.2M +62.7% Aug 13, 2024 10-Q 2024-08-13
Q1 2024 34.3M +16.3M +91% Mar 28, 2024 10-K 2024-03-28
Q3 2023 21.2M +11.5M +118% Nov 9, 2023 10-Q 2023-11-09
Q2 2023 21.1M +11.4M +118% Aug 14, 2023 10-Q 2023-08-14
Q1 2023 17.9M +8.47M +89.5% Mar 16, 2023 10-K/A 2023-05-16
Q3 2022 9.71M +257K +2.72% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 9.68M +230K +2.43% Aug 11, 2022 10-Q 2022-08-11
Q1 2022 9.46M +3.31M +53.8% Mar 10, 2022 10-K 2022-03-10
Q3 2021 9.45M +5.84M +161% Nov 9, 2021 10-Q 2021-11-09
Q2 2021 9.45M +5.87M +163% Aug 12, 2021 10-Q 2021-08-12
Q1 2021 6.15M -25.2M -80.4% Mar 11, 2021 10-K 2021-03-11
Q3 2020 3.62M -4.74M -56.7% Nov 12, 2020 10-Q 2020-11-12
Q2 2020 3.59M -4.51M -55.7% Aug 6, 2020 10-Q 2020-08-06
Q1 2020 31.4M +24.6M +366% Mar 13, 2020 10-K 2020-03-13
Q3 2019 8.35M +1.63M +24.3% Nov 6, 2019 10-Q 2019-11-06
Q2 2019 8.1M +3.55M +77.9% Aug 8, 2019 10-Q 2019-08-08
Q1 2019 6.72M -6.03M -47.3% Mar 14, 2019 10-K 2019-03-14
Q3 2018 6.72M -5.23M -43.7% Nov 7, 2018 10-Q 2018-11-07
Q2 2018 4.55M -25.6M -84.9% Aug 8, 2018 10-Q 2018-08-08
Q1 2018 12.7M -17.3M -57.6% Mar 1, 2018 10-K 2018-03-01
Q3 2017 11.9M -18.1M -60.2% Nov 9, 2017 10-Q 2017-11-09
Q2 2017 30.1M +94.8K +0.32% Jul 31, 2017 10-Q 2017-07-31
Q1 2017 30.1M +273K +0.92% Feb 23, 2017 10-K 2017-02-23
Q3 2016 30M +216K +0.73% Nov 10, 2016 10-Q 2016-11-10
Q2 2016 30M +218K +0.73% Aug 4, 2016 10-Q 2016-08-04
Q1 2016 29.8M +7.13M +31.5% Mar 9, 2016 10-K 2016-03-09
Q3 2015 29.8M +8.52M +40.1% Nov 12, 2015 10-Q 2015-11-12
Q2 2015 29.8M +8.65M +40.9% Aug 13, 2015 10-Q 2015-08-13
Q1 2015 22.7M +7.96M +54.1% Mar 26, 2015 10-K 2015-03-26
Q3 2014 21.3M +6.57M +44.7% Oct 30, 2014 10-Q 2014-10-30
Q2 2014 21.1M +6.46M +44% Aug 7, 2014 10-Q 2014-08-07
Q1 2014 14.7M +59.8K +0.41% Mar 11, 2014 10-K 2014-03-11
Q3 2013 14.7M +50.7K +0.35% Nov 7, 2013 10-Q 2013-11-07
Q2 2013 14.7M +107K +0.73% Aug 8, 2013 10-Q 2013-08-08
Q1 2013 14.7M +4.91M +50.3% Mar 7, 2013 10-K 2013-03-07
Q3 2012 14.7M +4.91M +50.4% Nov 7, 2012 10-Q 2012-11-08
Q2 2012 14.6M +4.85M +49.8% Jul 30, 2012 10-Q 2012-08-02
Q1 2012 9.75M Mar 8, 2012 10-K 2012-03-08
Q3 2011 9.75M Nov 1, 2011 10-Q 2011-11-03
Q2 2011 9.73M Aug 1, 2011 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.